Piper Sandler analyst Kashy Harrison reiterated an 'Overweight' rating on Codexis but reduced the price target from $9 to $8. This indicates a slightly less optimistic outlook on the stock's future valuation, despite maintaining a positive recommendation.
Piper Sandler analyst Kashy Harrison maintained an 'Overweight' rating on Codexis (CDXS) but lowered the price target from $9 to $8. This adjustment suggests that while the analyst still sees upside potential for the stock, the expected magnitude of that upside has decreased. For traders, this could lead to short-term downward pressure on CDXS as some investors might interpret the lower price target as a sign of weakening fundamentals or slower growth prospects. However, the maintained 'Overweight' rating implies that the analyst believes the stock is still undervalued at its current price, presenting a potential buying opportunity for long-term investors if the market overreacts to the price target reduction.